What’s New

This prospective pilot study assessed the efficacy of venous sinus stenting in patients with idiopathic intracranial hypertension (IIH). Source: AAO

• Posted on: Dec 4 2017
• By: Saratoga Opthalmology

This prospective case series compares the efficacy of a computer-assisted system versus manual marking for toric IOL alignment. Source: AAO

• Posted on: Dec 2 2017
• By: Saratoga Opthalmology

Researchers in Germany have implanted the human eye with a micro-sensor, called Eyemate™, that can continuously monitor IOP in patients with glaucoma. Source: AAO

• Posted on: Dec 1 2017
• By: Saratoga Opthalmology

On the heels of disappointing phase 2 results, Regeneron Pharmaceuticals, Inc. says it will discontinue development of their aflibercept/nesvacumab combination therapy for diabetic macular edema (DME) and wet AMD. Source: AAO

• Posted on: Nov 28 2017
• By: Saratoga Opthalmology

RxSight Inc. announced the approval of a first-of-its-kind system that can correct minor residual refractive errors by making postoperative adjustments to the IOL power. Source: AAO

• Posted on: Nov 27 2017
• By: Saratoga Opthalmology

This study finds that aqueous humor from retinoblastoma eyes contains tumor-derived DNA that can be analyzed as an alternative to tissue biopsy. Source: AAO

• Posted on: Nov 27 2017
• By: Saratoga Opthalmology

The Academy is seeking help from cataract surgeons to assist with a collaborative project for developing a patient-reported outcome (PRO) instrument. Source: AAO

• Posted on: Nov 21 2017
• By: Saratoga Opthalmology

The FDA has granted orphan status to IVMED-80, a daily eye drop for keratoconus. Source: AAO

• Posted on: Nov 21 2017
• By: Saratoga Opthalmology

These uveitis papers published in 2016 were selected by members of the American Uveitis Society for their outstanding teaching value for residents. Source: AAO

• Posted on: Nov 20 2017
• By: Saratoga Opthalmology

• Posted on: Nov 17 2017
• By: Saratoga Opthalmology